| |
|
|
|
Proteostasis Ther  
|
|
4.71 -0.12 (-0.02%) |
05-25 16:00 |
|
Open: |
4.86 |
Pre close: |
4.83 |
Target:
|
6.18 
|
|
High: |
4.86 |
Low: |
4.7 |
Resistance:
|
5.29
5.66
|
|
Volume: |
259,101 |
Market Cap: |
170M |
Support:
|
4.70
3.91
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.89
|
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
5.10 |
Signal(12,26,9): |
0.01 |
|
MA(100): |
4.59 |
Stochastic Oscillator |
%K(14,3):
|
14.18 |
|
MA(250): |
3.63  |
%D(3): |
20.92 |
|
Average Volume(K) |
3-Month: |
216541
|
52-Week |
High:
|
8.61 |
|
10-Days: |
35192 |
Low: |
1.41 |
|
RSI |
RSI(14):
|
39.60 |
Change(%): |
14.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.350 |
Return on Equity (ttm) |
-79.1 |
Shares Out. (M) |
34.81 |
|
EPS Est. Current Year |
-2.750 |
Return on Assets (ttm) |
-64.1 |
Shares Float (M) |
34.39 |
|
EPS Est. Next Year |
-2.450 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.20 |
|
EPS Est. Next Quarter |
-0.750 |
Qtrly Rev. Growth |
-7.7 |
% Held by Institutions |
54.90 |
|
Forward EPS |
-2.176 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
2237 |
|
Book Value (p.s.) |
2.640 |
EBITDA (p.s.) |
-1.329 |
P/E |
-2.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.78 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-49.08 |
P/S |
894404160.00 |
|
Operating Margin |
-1064.18 |
Levered Free Cash Flow
(M) |
-30.38 |
P/CF |
-3.34 |
|
|
|
|
|
|
